ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 11728
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
MOXTENZ 0,4MG TBL FLM 20
0207919 58/ 890/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,4MG TBL FLM 30
0207920 58/ 890/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,4MG TBL FLM 50
0207921 58/ 890/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,4MG TBL FLM 60
0207922 58/ 890/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,4MG TBL FLM 90
0207923 58/ 890/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,4MG TBL FLM 98
0207924 58/ 890/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,4MG TBL FLM 100
0207925 58/ 890/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,2MG TBL FLM 10
0207902 58/ 888/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,2MG TBL FLM 20
0207903 58/ 888/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,2MG TBL FLM 30
0207904 58/ 888/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,2MG TBL FLM 50
0207905 58/ 888/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MOXTENZ 0,2MG TBL FLM 98
0207908 58/ 888/16-C moxtenz.pdf moxtenz.pdf C02AC05 R
MULTAQ 400MG TBL FLM 20
0167349 EU/1/09/591/001 multaq.pdf multaq.pdf C01BD07 R
MULTAQ 400MG TBL FLM 50
0167350 EU/1/09/591/002 multaq.pdf multaq.pdf C01BD07 R
MULTAQ 400MG TBL FLM 60
0167351 EU/1/09/591/003 multaq.pdf multaq.pdf C01BD07 R
MULTAQ 400MG TBL FLM 100X1
0167352 EU/1/09/591/004 multaq.pdf multaq.pdf C01BD07 R
NAMUSCLA 167MG CPS DUR 30
0238356 EU/1/18/1325/001 namuscla.pdf namuscla.pdf C01BB02 R
NAMUSCLA 167MG CPS DUR 100
0238358 EU/1/18/1325/003 namuscla.pdf namuscla.pdf C01BB02 R
NAMUSCLA 167MG CPS DUR 200
0238359 EU/1/18/1325/004 namuscla.pdf namuscla.pdf C01BB02 R
NAMUSCLA 167MG CPS DUR 50
0238357 EU/1/18/1325/002 namuscla.pdf namuscla.pdf C01BB02 R

‹‹ ‹ 100 200 250 260 270 280 290 295 296 297 298 299 300 301 302 303 304 305 310 320 330 340 350 400 500 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 1. December 2022 at 00:08
Last update of price and payment data: 1. December 2022 at 00:08